Premium
Salivary gland disease in the era of COVID ‐19 pandemic
Author(s) -
Soldatova Liuba,
Rassekh Christopher H.,
Baloch Zubair W.,
Jalaly Jalal B.,
SedoraRoman Neda I.,
Loevner Laurie L.,
Cognetti David M.,
Witt Robert L.,
Dulguerov Pavel
Publication year - 2020
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26210
Subject(s) - pandemic , triage , covid-19 , medicine , disease , salivary gland , otorhinolaryngology , salivary gland cancer , contagious disease , coronavirus , health care , intensive care medicine , medical emergency , infectious disease (medical specialty) , virology , surgery , outbreak , political science , law
Coronavirus disease 2019 (COVID‐19) pandemic forced significant changes in current approach to outpatient evaluation of common otolaryngology complaints as hospitals around the world are trying to limit the spread of the virus and to preserve health care resources. These changes raise a lot of questions regarding patient triage and treatment decisions in clinical situations when it is unclear if the workup and management can be postponed. In this communication, we present our approach to evaluation and triage of new patients with complaints concerning for salivary gland disease.